Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Skyhawk Therapeutics
Entity

Skyhawk Therapeutics

Tracked across 1 events · 7 articles · First seen Mar 02, 2026 · Last active Mar 02, 2026

Sentiment
70
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Regulatory
Australia TGA Approves Skyhawk's SKY-0515 Eligibility
Skyhawk Therapeutics' drug, SKY-0515, has met the eligibility criteria for provisional approval in Australia, marking a significant step towards bringing a disease-modifying treatment for Huntington's disease to market. This could accelerate global approval.
Mar 02, 2026 · 7 articles
Relationships (2)
Australia===Therapeutic Goods Administration regulator ↔ Skyhawk Therapeutics The Australia===Therapeutic Goods Administration is the regulatory body for Skyh
Bill Haney CEO ↔ Skyhawk Therapeutics Bill Haney is the CEO of Skyhawk Therapeutics.
NEWSDESK
Track Skyhawk Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.